NAYA Biosciences Files Proxy Materials
Ticker: IVF · Form: DEFA14A · Filed: Feb 13, 2025 · CIK: 1417926
Sentiment: neutral
Topics: proxy-filing, corporate-actions
TL;DR
NAYA Bio filed more proxy docs, likely for shareholder votes. Check the details.
AI Summary
NAYA Biosciences, Inc. filed a Definitive Additional Materials proxy statement on February 13, 2025. This filing relates to the company's proxy materials, which were previously submitted. The company, formerly known as INVO Bioscience, Inc., is incorporated in Nevada and operates in the surgical and medical instruments sector.
Why It Matters
This filing indicates that NAYA Biosciences is proceeding with corporate actions requiring shareholder approval, as detailed in their proxy statement.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials, not indicating new risks or significant corporate events.
Key Players & Entities
- NAYA Biosciences, Inc. (company) — Registrant
- INVO Bioscience, Inc. (company) — Former company name
- February 13, 2025 (date) — Filing date
FAQ
What is the purpose of this DEFA14A filing?
This filing is for Definitive Additional Materials related to NAYA Biosciences, Inc.'s proxy statement, indicating further information or materials being provided to shareholders.
When was this filing submitted to the SEC?
The filing was submitted on February 13, 2025.
What was NAYA Biosciences, Inc. formerly known as?
NAYA Biosciences, Inc. was formerly known as INVO Bioscience, Inc.
In which state is NAYA Biosciences, Inc. incorporated?
NAYA Biosciences, Inc. is incorporated in Nevada (NV).
What is the primary business of NAYA Biosciences, Inc. according to its SIC code?
NAYA Biosciences, Inc.'s Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 124 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2025-02-13 13:53:59
Filing Documents
- formdefa14a.htm (DEFA14A) — 16KB
- proxy_001.jpg (GRAPHIC) — 819KB
- proxy_002.jpg (GRAPHIC) — 628KB
- 0001493152-25-006376.txt ( ) — 2006KB
From the Filing
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant  Filed by a Party other than the Registrant  Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 NAYA BIOSCIENCES, INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 2(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.